Navigation Links
Baxter And Halozyme Announce Positive Opinion For HyQvia For Treatment Of Primary And Secondary Immunodeficiencies In The European Union
Date:3/22/2013

utaneous site. The acute serious bacterial infection rate in the study was 0.025 per patient per year, which is below the required efficacy threshold of 1.0 (serious bacterial infections per patient per year). In the tolerability assessment of HyQvia, the most frequently reported adverse reactions were infusion site reactions (20% of infusions), headache (3% of infusions), fatigue (1% of infusions) and pyrexia (fever) (1% of infusions). Upon receiving marketing authorization from the European Commission, Baxter plans to launch HyQvia in selected countries in the European Union later this year.

"Recognizing that the path to approval for any biologic is a long journey, I would like to thank and congratulate the teams at Halozyme and Baxter who have worked tirelessly to advance this therapeutic option for patients," said Gregory I. Frost , Ph.D., president and chief executive officer, Halozyme Therapeutics.

About HyQvia
HyQvia is a product consisting of human normal immunoglobulin (IGSC, 10%) and recombinant human hyaluronidase (licensed from Halozyme Therapeutics). The two components are packaged together as a dual vial unit: IGSC provides the therapeutic effect and the recombinant human hyaluronidase facilitates the dispersion and absorption of the IGSC, increasing the bioavailability. The IGSC is a 10% solution that is prepared from human plasma consisting of at least 98% IgG, which contains a broad spectrum of antibodies.

HyQvia is indicated as replacement therapy in adults (> 18 years) in primary immunodeficiency syndromes and in myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections.

Important Safety Information
HyQvia should not be used by women who are pregnant, or are planning to become pregnant, or are breast-feeding.

About Immunodeficiency Disorders
Primary Immunode
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Halozyme Confirms Baxter Has Received A Complete Response Letter For HyQ BLA
2. Halozyme Therapeutics to Present at the Barclays 2013 Global Healthcare Conference
3. Halozyme Reports Fourth Quarter and Year End 2012 Financial Results
4. Halozyme Announced Roche Filed A Marketing Authorization Application For Subcutaneous MabThera
5. Halozyme Therapeutics To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
6. Halozyme to Host Third Quarter Financial Results Conference Call
7. Halozyme Reports Second Quarter 2012 Financial Results
8. Halozymes Ultrafast Insulin Formulations Improved Postprandial Glycemic Control in Patients Living with Type 1 Diabetes: Phase 2 Study Results Presented at ADA 2012
9. Halozyme Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
10. Halozyme Reports First Quarter 2012 Financial Results
11. Halozyme to Host First Quarter 2012 Financial Results Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... , July 10, 2014  The U.S. Department ... three-year grant to University Hospitals (UH) Case Medical Center ... new national model aimed at improving care for patients ... Care," the project will test a unique model developed ... with late-stage disease, significant comorbidities, or demonstrated need for ...
(Date:7/10/2014)... AMBLER, Pa. , July 10, 2014 /PRNewswire/ ... visited Moberg Research,s (Moberg) medical device manufacturing facility. ... how Moberg,s advanced neurological monitors facilitate cutting-edge research ... 2011, Rep. Kennedy and mental health advocate, ... non-profit organization dedicated to fostering fundamental changes that ...
(Date:7/10/2014)...  Decision Resources Group finds that while more ... are willing to prescribe Durata,s Dalvance (dalbavancin) and ... OPAT, approximately two-thirds of the respondents reported a ... inpatients. However, our findings indicate that nearly two-thirds ... OPAT following hospital discharge, and most are discharged ...
Breaking Medicine Technology:University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 2University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 3University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 4Representative Patrick Kennedy visits Moberg's medical device facility to discuss improvement in brain injury care 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3
... ... ... ... ...
... ... ... ... , , ...
Cached Medicine Technology:Microfluidics International Corporation Announces Fourth Quarter and Year-End 2009 Financial Results 2Microfluidics International Corporation Announces Fourth Quarter and Year-End 2009 Financial Results 3Microfluidics International Corporation Announces Fourth Quarter and Year-End 2009 Financial Results 4Microfluidics International Corporation Announces Fourth Quarter and Year-End 2009 Financial Results 5Microfluidics International Corporation Announces Fourth Quarter and Year-End 2009 Financial Results 6Microfluidics International Corporation Announces Fourth Quarter and Year-End 2009 Financial Results 7Microfluidics International Corporation Announces Fourth Quarter and Year-End 2009 Financial Results 8Microfluidics International Corporation Announces Fourth Quarter and Year-End 2009 Financial Results 9Microfluidics International Corporation Announces Fourth Quarter and Year-End 2009 Financial Results 10Microfluidics International Corporation Announces Fourth Quarter and Year-End 2009 Financial Results 11Microfluidics International Corporation Announces Fourth Quarter and Year-End 2009 Financial Results 12Microfluidics International Corporation Announces Fourth Quarter and Year-End 2009 Financial Results 13Chimerix CEO George Painter, Ph.D., to Speak on Improving Biodefense Product Discovery and Development Strategies at Institute of Medicine Workshop 2Chimerix CEO George Painter, Ph.D., to Speak on Improving Biodefense Product Discovery and Development Strategies at Institute of Medicine Workshop 3
(Date:7/10/2014)... (PRWEB) July 11, 2014 The Capital ... has performed the first procedure in a clinical trial ... inserted in the leg. , During the procedure, done ... Veznedaroglu, an endovascular neurosurgeon, threaded a tiny catheter through ... the body and neck and into the brain. Once ...
(Date:7/10/2014)... acids had healthier joints than those fed diets high ... to Duke Medicine researchers. , The findings, published in ... on July 11, 2014, suggest that unhealthy dietary fats ... osteoarthritis. , "Our results suggest that dietary factors play ... link between obesity and osteoarthritis," said Farshid Guilak, Ph.D., ...
(Date:7/10/2014)... More than 200 experts on aggression, ... street violence, will attend the 21st World Meeting of ... (ISRA) at the Loews Atlanta Hotel, July 15-19. , ... world meeting, which is held every other year on ... together leading scholars from more than 20 different countries, ...
(Date:7/10/2014)... (PRWEB) July 10, 2014 Fatigue, ... for an increasing number of accidents in the ... Safety Reboot. The articles highlight safety issues that ... 317 million accidents occur on the job annually, ... features continue to explore "preventable workplace accidents." , ...
(Date:7/10/2014)... Wisconsin (PRWEB) July 10, 2014 Ticketability.com has ... Tour,” and now Paul McCartney tickets for San Diego are ... in San Diego since 1976, and the newly added September ... California fans. , Click Here to view the ... tickets for Petco Park will become available to the general ...
Breaking Medicine News(10 mins):Health News:New Trial Delivers Chemotherapy to Brain Tumor Through Artery in Leg 2Health News:New Trial Delivers Chemotherapy to Brain Tumor Through Artery in Leg 3Health News:Omega 3 fatty acids lessen severity of osteoarthritis in mice 2Health News:Georgia State Hosts National Conference On Aggression 2Health News:Georgia State Hosts National Conference On Aggression 3Health News:Georgia State Hosts National Conference On Aggression 4Health News:Safety Reboot Magazine Focuses on: Why Extended Hours is Dangerous in the Workplace; Why Custodial Work Can be Dangerous; and Improving Safety for Roofers 2Health News:Safety Reboot Magazine Focuses on: Why Extended Hours is Dangerous in the Workplace; Why Custodial Work Can be Dangerous; and Improving Safety for Roofers 3Health News:Paul McCartney Tickets for San Diego: Ticketability.com Announces Discounted Tickets for McCartney’s Tour Stop at Petco Park on September 28 2
... Every Birth is Safe for Pregnant Women , ... , , ... ... NEW YORK , March 22 ...
... ... ... ... WASHINGTON , March 22 With the passage of the historic health care legislation, the National Medical ...
... has been a major increase in the incidence of ... differing opinions as to why this is (environment, vaccines, ... are still many children who have autistic traits that ... the support they need through educational or health services. ...
... Cycling jerseys and ... ... announced today the addition of a durable, visible and practical backpack for cyclists with ... to help remind motorists to give cyclists at least 3 feet clearance when passing them from ...
... and Services for the Aging, on passage of Health Reform Legislation: , ... , , ... ... "We commend the U.S. ...
... Capital 2010 High Yield Bond and Syndicated Loan Conference in Phoenix, Ariz. , on March 24-26, 2010 . , ... , , ... ... HealthSouth Senior Vice ...
Cached Medicine News:Health News:Amnesty International Urges Congress to Turn Attention to Needed Reforms on Maternal and Childbirth Care 2Health News:Amnesty International Urges Congress to Turn Attention to Needed Reforms on Maternal and Childbirth Care 3Health News:Amnesty International Urges Congress to Turn Attention to Needed Reforms on Maternal and Childbirth Care 4Health News:Amnesty International Urges Congress to Turn Attention to Needed Reforms on Maternal and Childbirth Care 5Health News:National Medical Association, Health System Reform - From Legislation to Implementation 2Health News:National Medical Association, Health System Reform - From Legislation to Implementation 3Health News:New Backpack for Cyclists Sends a Polite Message to Motorists: '3 Feet Please' 2Health News:New Backpack for Cyclists Sends a Polite Message to Motorists: '3 Feet Please' 3Health News:AAHSA Statement on Passage of Health Reform Legislation 2Health News:HealthSouth To Present at Barclays Capital 2010 High Yield Bond and Syndicated Loan Conference 2Health News:HealthSouth To Present at Barclays Capital 2010 High Yield Bond and Syndicated Loan Conference 3
Part of the GraFix® Cruciate Reconstruction System, which is designed to facilitate arthroscopic anterior cruciate ligament reconstructions....
... Sgarlato Lab's bring a new standard in the ... by Sgarlato Labs. Made of medical grade silicone, ... patient with a high level of flexibility while ... Rods are available in varying stiffnesses. Lengths are ...
... Implant (KGTI) system offers the latest technology ... MPJ. The implant system is anatomically designed ... ,The KGTI is the most advanced reconstructive ... on the market today. The system consists ...
... has been approved for use as an ... seizures in adults and adolescents over 12 ... that are refractory to antiepileptic medications. This ... controlled, clinical trials. Efficacy, measured as median ...
Medicine Products: